Anuh Pharma Limited (ANUHPHR) — Corporate Action | 20 May 2026(2 announcements)

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Corporate Action 🔴 High Importance Neutral 📄 PDF

Anuh Pharma Limited announced on May 20, 2026, its FY2025-26 audited results with a proposed dividend of ₹1.50 per share (30% payout) payable after the AGM on August 12, 2026, requiring shareholders to be registered by August 5. The filing confirms reappointments of directors including Bipin Shah and Arun Todarwal, new quality leadership hires, and auditor appointments, while noting no promoter reclassification requests were approved.

2 Corporate Action 🔴 High Importance Neutral 📄 PDF

Anuh Pharma Limited announced a Rs 1.50 per share dividend (30% payout on Rs 5 face value) for FY 2025-26, with record date set for 5 August 2026 and AGM scheduled for 12 August 2026. The audited financials show revenue of Rs 77,165.74 lakhs and PAT of Rs 4,104.61 lakhs, while EBITDA margin improved to 9.63% on adjusted basis. The Board reappointed directors including Bipin Nemchand Shah and Arun Lalchand Todarwal, and appointed P.N. Rao as General Manager - Quality effective 1 June 2026. Internal and cost auditors were also confirmed for FY 2026-27.

About Anuh Pharma Limited (ANUHPHR)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹896.2 Cr P/E: 20.3 ROE: 12.5% ROCE: 17.2% Div Yield: 1.68%

View full ANUHPHR stock details →

📡 Get AI alerts when ANUHPHR files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANUHPHR — Free

📊 More ANUHPHR filings

See all ANUHPHR filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ANUHPHR files new disclosures

Track ANUHPHR filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ANUHPHR — Free

Free account · 2 AI queries/day